The Alliance for Regenerative Medicine (ARM) is an international community of small and large companies, non-profit research institutions, patient organizations, and other sector stakeholders dedicated to realizing the promise of regenerative medicine for patients around the world.
ARM’s events bring together industry leaders, investors, policy makers, clinicians, and patients to network, partner, and learn about the latest clinical and commercial successes and challenges facing the sector.
The Cell & Gene Meeting on the Mesa is a three-day conference bringing together senior executives and top decision-makers in the industry with the scientific community to advance cutting-edge research into cures. The meeting features a nationally recognized Scientific Symposium, attended by leading researchers and clinical experts from around the globe, in conjunction with the industry’s premier annual Partnering Forum, the first event of its kind dedicated solely to facilitating connections in this sector. Combined, these meetings attract over 950 attendees, fostering key partnerships through more than 1,450 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.
Regenerative medicine includes gene therapies, cell therapies, and tissue-engineered products intended to augment, repair, replace, or regenerate organs, tissues, cells, genes, and metabolic processes in the body.
Regenerative medicine aims to alter the current practice of medicine by treating the root causes of disease and disorders.
ARM takes the lead on the most important issues facing the regenerative medicine and advanced therapy sector today:
ARM is a global community of therapeutic companies small & large, non-profit research institutions, patient organizations, and tool and technology providers. Working with our members and policymakers, we foster investment, research & development, and the successful commercialization of safe and effective treatments and cures for patients around the world.
